U.S. Healthtech Stock News

If you are wondering whether D.R. Horton at around US$155 a share still offers value, you are not alone. That is exactly what this article will unpack. The stock has had mixed recent returns, with a 0.8% decline over the last 7 days, a 2.6% gain over 30 days, and returns of 7.0% year to date and 6.9% over the last year, on top of a 70.0% return over 3 years and 110.9% over 5 years. Recent coverage around large US homebuilders has focused on how investors are weighing long term housing demand...

J.B. Hunt Transport Services (JBHT) just wrapped up FY 2025 with fourth quarter revenue of US$3.1b and basic EPS of US$1.90, alongside net income of US$181.1m. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.1b in Q4 2025, while basic EPS shifted from US$1.53 to US$1.90 over the same period. Trailing twelve month EPS stands at US$6.12 on revenue of US$12.0b. With net margin at 5.0% and slightly higher than last year, the focus this season is on how efficiently...

If you are wondering whether Doximity is attractively priced at its current level or if the market is overlooking something in plain sight, this article is for you. The stock is at US$41.26 after a 5.8% decline over the last 7 days, a 5.6% decline over 30 days and a 4.7% decline year to date, while the 3 year return sits at 27.8% and the 1 year return at a 23.2% decline. Recent coverage around Doximity has focused on its role as a digital platform for medical professionals and how that...

Mountain Pacific Bancorp (MPCB) just wrapped up FY 2025 with fourth quarter revenue of about US$10.0 million and net income of US$3.1 million, set against a trailing twelve month total of US$38.7 million in revenue and US$13.1 million in net income. The company has seen revenue move from US$28.7 million to US$38.7 million on a trailing basis, while trailing earnings growth of 67.1% and a net profit margin of 33.9% frame a results season in which profitability and efficiency are front and...

Why this new drug delivery alliance matters for Stevanato Group Datwyler’s new collaboration with LTS Device Technologies and Stevanato Group (STVN) centers on large volume, on body subcutaneous drug delivery, targeting in home use and the growing role of biologic therapies. See our latest analysis for Stevanato Group. Stevanato Group’s latest news on large volume drug delivery comes after a tougher period for the stock, with a 19.19% decline in the 3 month share price return and a 13.33%...

Earlier this month, American Financial Group, Inc. declared a regular cash dividend of US$0.88 per common share, payable on January 27, 2026, to shareholders of record as of January 15, 2026. Wells Fargo has now initiated coverage of American Financial Group with an Overweight rating, highlighting expectations for better 2026 growth supported by the company’s relatively low property exposure and focus on maintaining stable margins and return on equity. We’ll now examine how Wells Fargo’s...

Niagen Bioscience (NAGE) has drawn fresh attention after announcing a partnership with Truemed that lets qualified customers buy Tru Niagen using Health Savings Account and Flexible Spending Account funds on its direct website. See our latest analysis for Niagen Bioscience. That HSA and FSA payment update arrives after a period of softer momentum, with a 90 day share price return of a 15.55% decline and a year to date share price return of a 0.96% decline, even as the three year total...

If you are wondering whether SouthState Bank's share price reflects its true worth, you are not alone. This article walks through what the current market price might be implying about value. The stock last closed at US$98.43, with returns of 0.8% over the past week, 0.8% over the last month, 4.5% year to date and 1.2% over the past year, while the 3 year and 5 year returns sit at 37.1% and 40.1% respectively. Recent moves in U.S. regional bank shares have kept investor attention on balance...

Axogen (AXGN) is back in focus after securing FDA approval and a biologics license for its Avance Nerve Graft, alongside preliminary 2025 guidance that indicates higher fourth quarter and full year revenue. See our latest analysis for Axogen. The FDA approval and updated 2025 revenue guidance come after a sharp shift in sentiment, with a 90-day share price return of 86.98% and a 1-year total shareholder return of 71.48% pointing to building momentum despite recent short term volatility. If...

In its latest reported quarter, Freshpet delivered a 14% year-over-year revenue increase and surpassed analysts’ expectations on both revenue and earnings, with leadership emphasizing category-leading growth and strong financial and operational performance. This combination of outperformance against estimates and management’s confidence in the business highlights how Freshpet’s recent execution may be reinforcing its longer-term margin and growth ambitions. We’ll now explore how Freshpet’s...

Paycom Software: Recent Returns and Business Snapshot Paycom Software (PAYC) has been under pressure recently, with the stock showing negative returns over the past week, month and past 3 months. This performance has prompted some investors to reassess its current valuation. See our latest analysis for Paycom Software. At a share price of US$148.41, Paycom’s recent 11% 30 day share price decline and 26% 90 day share price decline sit alongside a 1 year total shareholder return decline of 29%...

In early January 2026, Xeris Biopharma Holdings, Inc. raised its full-year 2025 revenue guidance to approximately US$292 million, above its prior US$285–US$290 million range, signaling better-than-planned top-line performance. This upward revision suggests the company’s commercial portfolio is gaining more traction than initially forecast, reshaping how investors may assess its revenue potential and operational progress. We’ll now examine how this higher 2025 revenue guidance intersects...

In recent days, Venture Global has drawn attention after revising its adjusted EBITDA outlook for late 2025 while continuing to export 128 cargos of LNG during a period of heightened winter energy demand. At the same time, concerns around eroding margins, a complex capital structure, and litigation risks have sharpened the focus on how much value ultimately reaches common shareholders. With these developments and strong winter-driven LNG exports in mind, we’ll now examine how they shape...

NioCorp Developments Ltd. recently reported final assay results from its 2025 drilling campaign at the Elk Creek Critical Minerals Project in Nebraska, which aligned with internal expectations and supported confidence in mineralization continuity, while also announcing progress on development funding, land acquisition, and scandium alloy capabilities. Although these assay results are not yet classified as reserves or resources under SEC or Canadian standards, the combination of U.S...

Recent attention on Grab Holdings (GRAB) has picked up as investors weigh rising competition, potential Indonesian commission cuts, and ongoing cost pressures against the company’s technology investments and partnership activity. See our latest analysis for Grab Holdings. The recent slide in Grab’s 30 day share price return of 10.06% and 90 day share price return of 22.34%, alongside regulatory headlines in Indonesia and the Infermove robotics acquisition, contrasts with a milder 1 year total...

AGCO (AGCO) is back in focus after its Fendt, Massey Ferguson and PTx brands collected seven AE50 awards, while Citi updated its 2026 margin outlook, putting the company’s precision agriculture push under the spotlight for investors. See our latest analysis for AGCO. AGCO’s precision agriculture push and recent AE50 awards come as the share price trades at $111.35, with a 30 day share price return of 4.69% and a 1 year total shareholder return of 10.73%. This suggests momentum has been...

Warrior Met Coal, Inc. recently completed its approximately US$1.00 billion Blue Creek Mine in Alabama, a longwall operation expected to produce an average of 6.0 million short tons of metallurgical coal annually over its first decade while adding more than 300 local jobs and integrated rail and barge logistics. Coupled with newly awarded federal coal leases expected to support more than 40 years of mining and over 500 additional jobs, these moves materially expand Warrior Met Coal’s access...

Recently, Chime Financial reported slowing growth and sequential declines in purchase volume, prompting investors to reassess the fintech’s competitive position and outlook. At the same time, Chime is pushing into higher-margin products, in-house payment processing, and AI-driven features to broaden its customer base and improve unit economics. We’ll now examine how Chime’s shift to its own payment processing platform could influence the company’s investment narrative and long-term...

In recent weeks, Axon Enterprise has seen heightened interest ahead of its upcoming earnings, with AI-driven institutional trading strategies signaling positive sentiment even as analysts project a year-over-year earnings-per-share decline alongside strong double-digit revenue growth. At the same time, Axon agreed to a US$5.55–US$8.50 million class action settlement over Washington job-posting disclosures, a relatively modest legal cost that contrasts with investors’ focus on its expanding...

Recently, commentators including Jim Cramer have highlighted Sirius XM’s ongoing struggle to generate growth amid rising competition from streaming platforms, even as it maintains a yield near 5% and seeks support from auto sector trends. At the same time, PodcastOne’s multiyear extension with Adam Carolla, bringing The Adam Carolla Show to SiriusXM’s Megyn Kelly Channel, underscores SiriusXM’s continued push into high-profile podcast content distribution despite broader concerns about its...

PNC Financial Services Group has reported its fourth-quarter and full-year 2025 results, with net interest income rising to US$3,731 million in the quarter and quarterly net income increasing to US$2,020 million, while net loan charge-offs fell to US$162 million from US$250 million a year earlier. This combination of higher earnings per share from continuing operations and lower credit losses, alongside ongoing capital actions like debt redemptions and dividends, highlights management’s...

Event overview and why Taylor Morrison Home matters now Taylor Morrison Home (TMHC) has drawn fresh attention after recent share price moves, with the stock around $63.27 and mixed return patterns over the past year prompting investors to reassess its performance and valuation. See our latest analysis for Taylor Morrison Home. Recent trading has cooled slightly, with a 1 day share price return of 1.37% decline and a 7 day share price return of 3.18% decline, while the 1 month share price...

PPL (PPL) is back in focus as investors weigh two key forces: an upcoming quarterly earnings release that is expected to show a double digit profit increase, and a recent 3.7% default electricity rate hike. See our latest analysis for PPL. PPL’s recent 1-day share price return of 3.14% and 7-day share price return of 6.48% at a latest share price of $36.83 follow growing attention on its earnings outlook and the 3.7% default rate hike. Over the longer term, total shareholder returns of 14.35%...

If you are wondering whether Olin's current share price fairly reflects the business, this article will walk through what the numbers actually say about value. Over the short term the stock has had mixed moves, with a 1.9% decline over the last 7 days, a 15.3% gain over the last 30 days, and an 8.6% return year to date. The 1 year and 3 year returns of 28.2% and 55.6% respectively have been weaker, and the 5 year return sits around flat at 0.2%. Recent price moves sit against a backdrop of...